AKT1 and hepatocellular carcinoma: A study of hepatocellular carcinoma (HCC) cells from patients showed that siRNA-mediated knockdown of eEF1A2 expression diminished the activation of both Akt and mTOR signaling, suggesting that eEF1A2 is an upstream inducer of PI3K [15].